INTRODUCTION: The time of day in which craving, withdrawal, and other tobacco abstinence symptoms are assessed may moderate the influences of abstinence or medication on those symptoms. METHODS:Participants were 209 smokers participating in a 4-week crossover study assessing symptoms due to smoking versus abstinence and while usingnicotine (21 mg) versus placebo patch when abstinent. None was trying to quit permanently during the study. Abstinence was verified daily by a carbon monoxide level of less than 5 ppm. Participants completed craving (two measures), total withdrawal, and positive affect (PA) and negative affect forms three times per day: in the morning, upon arrival at the clinic in the afternoon, and in the evening. All comparisons of the effects of time of day, abstinence, and nicotine patch treatment were within subjects. RESULTS: Results showed a main effect of time of day on all measures while smoking, wherein PA was higher and the other four measures lower, during afternoon versus morning or evening ratings. Time of day interacted with abstinence on both craving measures, but not the other measures, such that abstinence increased craving less in the morning versus the other times. Time of day also interacted with nicotine (vs. placebo) patch effects in alleviating negative mood to a greater degree during evening versus morning or afternoon ratings. DISCUSSION: The data suggest that, compared with traditional single assessments of symptoms at midday, assessments at several times of the day may reveal greater overall levels of symptoms and perhaps greater effects of abstinence and nicotine replacement on select abstinence symptoms.
RCT Entities:
INTRODUCTION: The time of day in which craving, withdrawal, and other tobacco abstinence symptoms are assessed may moderate the influences of abstinence or medication on those symptoms. METHODS:Participants were 209 smokers participating in a 4-week crossover study assessing symptoms due to smoking versus abstinence and while using nicotine (21 mg) versus placebo patch when abstinent. None was trying to quit permanently during the study. Abstinence was verified daily by a carbon monoxide level of less than 5 ppm. Participants completed craving (two measures), total withdrawal, and positive affect (PA) and negative affect forms three times per day: in the morning, upon arrival at the clinic in the afternoon, and in the evening. All comparisons of the effects of time of day, abstinence, and nicotine patch treatment were within subjects. RESULTS: Results showed a main effect of time of day on all measures while smoking, wherein PA was higher and the other four measures lower, during afternoon versus morning or evening ratings. Time of day interacted with abstinence on both craving measures, but not the other measures, such that abstinence increased craving less in the morning versus the other times. Time of day also interacted with nicotine (vs. placebo) patch effects in alleviating negative mood to a greater degree during evening versus morning or afternoon ratings. DISCUSSION: The data suggest that, compared with traditional single assessments of symptoms at midday, assessments at several times of the day may reveal greater overall levels of symptoms and perhaps greater effects of abstinence and nicotine replacement on select abstinence symptoms.
Authors: S Shiffman; C A Elash; S M Paton; C J Gwaltney; J A Paty; D B Clark; K S Liu; M E Di Marino Journal: Addiction Date: 2000-08 Impact factor: 6.526
Authors: Vincenzo Teneggi; Stephen T Tiffany; Lisa Squassante; Stefano Milleri; Luigi Ziviani; Alan Bye Journal: Psychopharmacology (Berl) Date: 2002-08-27 Impact factor: 4.530
Authors: Paul Cinciripini; David Wetter; Gail Tomlinson; Janice Tsoh; Carl De Moor; Lynn Cinciripini; John Minna Journal: Nicotine Tob Res Date: 2004-04 Impact factor: 4.244
Authors: Suzanne M Colby; Adam M Leventhal; Linda Brazil; Johanna Lewis-Esquerre; L A R Stein; Damaris J Rohsenow; Peter M Monti; Raymond S Niaura Journal: Nicotine Tob Res Date: 2009-11-23 Impact factor: 4.244
Authors: Megan E Piper; Tanya R Schlam; Jessica W Cook; Megan A Sheffer; Stevens S Smith; Wei-Yin Loh; Daniel M Bolt; Su-Young Kim; Jesse T Kaye; Kathryn R Hefner; Timothy B Baker Journal: Psychopharmacology (Berl) Date: 2011-03-18 Impact factor: 4.530
Authors: Cynthia A Conklin; Isabella Soreca; David J Kupfer; Yu Cheng; Ronald P Salkeld; Joel M Mumma; John M Jakicic; Christopher J Joyce Journal: Exp Clin Psychopharmacol Date: 2017-07-06 Impact factor: 3.157
Authors: Elias M Klemperer; John R Hughes; Catherine E Peasley-Miklus; Peter W Callas; Jessica W Cook; Joanna M Streck; Nicolas E Morley Journal: Nicotine Tob Res Date: 2021-01-22 Impact factor: 4.244